The Sudip Pharma IPO opens on November 21, 2025, and will close on November 25, 2025. The Sudip Pharma IPO is a book-build issue. The company will raise approximately ₹895 crore through the IPO, consisting of a fresh issue of shares worth ₹95.00 crore and an offer for sale of 1,34,90,726 equity shares with a face value of ₹1.
The price band for the Sudip Pharma IPO is ₹563 to ₹593 per share. The retail share is 35%, QIBs 50%, and HNIs 15%. The Sudip Pharma IPO will be listed on the BSE and NSE on November 28, 2025. The allotment for the Sudip Pharma IPO will take place on November 26, 2025.
The company reported revenue of ₹511.33 crore in 2025, compared to ₹465.38 crore in 2024. The company reported a profit of ₹138.69 crore in 2025, compared to ₹133.15 crore in 2024. Based on the financials, IPO investors should invest in the IPO GMP for the long term.
Sudeep Pharma IPO Details
| IPO Open Date | November 21, 2025 |
| IPO Close Date | November 25, 2025 |
| Face Value | ₹1 Per Equity Share |
| IPO Price Band | ₹563 to ₹593 Per Share |
| Issue Size | Approx ₹895 Crores |
| Fresh Issue | Approx ₹95.00 Crores |
| Offer for Sale: | Approx 1,34,90,726 Equity Shares |
| Issue Type | Book build Issue |
| IPO Listing | BSE, NSE |
| DRHP Draft Prospectus |  |
| RHP Draft Prospectus | |
Sudeep Pharma IPO Market Lot
The Sudeep Pharma IPO minimum market lot is 25 shares with ₹14,825 application amount. The retail investors can apply up-to 13 lots with 325 shares of ₹1,92,725 amount.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 25 | ₹14,825 |
| Retail Maximum | 13 | 325 | ₹1,92,725 |
| S-HNI Minimum | 14 | 350 | ₹2,07,550 |
| S-HNI Maximum | 67 | 1,675 | ₹9,93,275 |
| B-HNI Minimum | 68 | 1,700 | ₹10,08,100 |
IPO Reservation
| Investor Category | Share Offered | -% Shares |
| Anchor Investor | – Shares | -% |
| QIB (Ex. Anchor) | – Shares | 50% |
| NII Shares Offered | – Shares | 15% |
| Retail Shares Offered | – Shares | 35% |
Sudeep Pharma IPO Anchor Investors
| Anchor Bidding Date | November 20, 2025 |
| Anchor Investors List | |
| Shares Offered | [.] Shares |
| Anchor Size | [.] Cr. |
| lock-in period end date 50% shares (30 Days) | December 26, 2025 |
| lock-in period end date 50% shares (90 Days) | February 24, 2026 |
Sudeep Pharma IPO Dates
The Sudeep Pharma IPO date is November 21 and the close date is November 25 The Sudeep Pharma IPO allotment will be finalized on November 26 and the IPO listing on November 28.
| IPO Open Date: | November 21, 2025 |
| IPO Close Date: | November 25, 2025 |
| Basis of Allotment: | November 26, 2025 |
| Refunds: | November 27, 2025 |
| Credit to Demat Account: | November 27, 2025 |
| IPO Listing Date: | November 28, 2025 |
| IPO Bidding Cut-off Time: | November 25, 2025 – 5 PM |
Promoters and Holding Pattern
The promoters of the company are Sujit Jaysukh Bhayani, Avani Sujit Bhayani, Shanil Sujit Bhayani, Sujeet Jaysukh Bhayani Huf, Riva Resources Private Limited And Bhayani Family Trust.
| Particular | Shares | % Share |
| Promoter Holding Pre Issue | 11,13,46,602 | 89.37% |
| Promoter Holding Post Issue | 11,29,48,626 | 76.15% |
Objects of the Issue & Utilisation of proceeds
| Purpose | Crores |
| Capital expenditure towards procurement of machinery for the production line located at Nandesari Facility I | 75.81 |
| General corporate purposes | – |
About tha company
Founded in 1989, Sudeep Pharma Limited is one of the leading manufacturers of excipients and specialty ingredients for the pharmaceutical, food, and nutrition industries. They aim to support the global healthcare ecosystem by making their products available in over 100 countries and supplying over 200 products. To foster innovation in their work, they utilize their own in-house technologies for encapsulation, spray drying, granulation, trituration, liposomal preparations, and blends.
Their business is essentially divided into two areas: 1) pharmaceutical, food, and nutrition, which includes key mineral salts such as calcium, zinc, iron, potassium, magnesium, sodium, and copper, and 2) specialty ingredients, which include micronutrient premixes, encapsulated ingredients, granular minerals, and triturated blends. Furthermore, Sudeep Pharma operates six manufacturing facilities with a total production capacity of 50,000 metric tons.
Sudeep Pharma IPO Company Financial Report
Amount ₹ in Crores
| Period Ended | Revenue | Expense | PAT | Assets |
| 2022 | ₹351.00 | ₹282.46 | ₹49.80 | ₹345.00 |
| 2023 | ₹438.26 | ₹352.28 | ₹62.32 | ₹420.11 |
| 2024 | ₹465.38 | ₹290.56 | ₹133.15 | ₹513.87 |
| 2025 | ₹511.33 | ₹328.48 | ₹138.69 | ₹717.17 |
| June 2025 | ₹130.08 | ₹86.00 | ₹31.27 | ₹922.26 |
Sudeep Pharma IPO Valuation – FY2025
Check Sudeep Pharma IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| KPI | Values |
| ROE: | 28.13% |
| ROCE: | 29.82% |
| EBITDA Margin: | 39.70% |
| PAT Margin: | 27.63% |
| Debt to equity ratio: | 0.20 |
| Earning Per Share (EPS): | ₹12.78 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 27.88% |
| Net Asset Value (NAV): | ₹45.86 |
IPO Lead Managers aka Merchant Bankers
- ICICI Securities Ltd.
- IIFL Capital Services Ltd.
Company Address
Sudeep Pharma Ltd.
129/1/A,
GIDC Estate,
Nandesari,
Vadodara, Gujarat, 391340
Phone: +91 265 284 0656
Email: cs.sudeep@sudeepgroup.com
Website: https://www.sudeeppharma.com/
IPO Registrar
MUFG Intime India Pvt. Ltd.
Phone: +91-22-4918 6270
Email: sudeeppharma.ipo@in.mpms.mufg.com
Website: https://in.mpms.mufg.com/Initial_Offer/public-issues.html